# The Clinical Trial of Chinese Herbal Medicine SaiLuoTong Capsule

Study · id `cardio:ct-nct01978730` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01978730](<https://clinicaltrials.gov/study/NCT01978730>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01978730

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 372 participants.

## Technical summary

Registry record NCT01978730. Randomized; quadruple masking; primary purpose treatment. Start 2011-12 (registry gives no type); primary completion 2014-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 372 participants (planned count; ClinicalTrials.gov record NCT01978730, source copy `cardio:ctgov-nct01978730-2014-05-08`, retrieved 2026-10-26)
- Start date: 2011-12 (registry gives no type) (ClinicalTrials.gov record NCT01978730, source copy `cardio:ctgov-nct01978730-2014-05-08`, retrieved 2026-10-26)
- Primary completion: 2014-07 (anticipated) (ClinicalTrials.gov record NCT01978730, source copy `cardio:ctgov-nct01978730-2014-05-08`, retrieved 2026-10-26)
- Completion: 2014-07 (anticipated) (ClinicalTrials.gov record NCT01978730, source copy `cardio:ctgov-nct01978730-2014-05-08`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01978730, source copy `cardio:ctgov-nct01978730-2014-05-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01978730-2014-05-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Clinical Trial of Chinese Herbal Medicine SaiLuoTong Capsule
- Condition: Vascular Dementia
- Intervention (Drug): high dose group of SaiLuoTong capsule
- Intervention (Drug): low dose group of SaiLuoTong
- Intervention (Drug): the control group
- Lead sponsor: Shineway Pharmaceutical Co.,Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: c6884c09ae5559c83c5538cc52dbcb09963da9737d5efa7fa8113a2e679fd68a
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
